Today: 11 April 2026
Browse Category

NASDAQ:SGEN 9 January 2026

Merck (MRK) stock today: $32 billion Revolution talks and CDC vaccine shift put Feb. 3 in play

Merck (MRK) stock today: $32 billion Revolution talks and CDC vaccine shift put Feb. 3 in play

Merck shares rose 0.4% to $111.41 Friday after a report said it is in talks to buy Revolution Medicines for $28–32 billion. Revolution shares jumped 16% in extended trading. Merck just completed a $221.50-per-share tender offer for Cidara Therapeutics and said the deal will raise 2026 R&D expense by $9 billion. Analysts warned U.S. vaccine policy changes could cut Merck revenue by $2 billion annually.

Stock Market Today

  • Luckin Coffee Valuation Under Spotlight After Recent Share Price Fluctuations
    April 11, 2026, 1:02 AM EDT. Luckin Coffee (OTCPK:LKNC.Y) shows mixed share price performance, declining in one day but gaining slightly over a week, though down over longer periods. Its 14.87% total shareholder return over one year contrasts with weaker year-to-date performance, signaling cooled momentum. Current price at $32.36 sits below analyst fair value estimate of $45.54, implying undervaluation based on expected growth and profitability gains. Investments in supply chain infrastructure aim to boost margins through vertical integration. However, risks such as market saturation from rapid store growth and rising delivery costs could affect profitability. Investors should weigh potential rewards against risks before committing new capital, while considering a broader set of companies to diversify opportunities.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 1:16 AM EDT Luckin Coffee Valuation Under Spotlight After Recent Share Price Fluctuations April 11, 2026, 1:02 AM EDT. Luckin Coffee (OTCPK:LKNC.Y) shows mixed share price performance, declining in one day but gaining slightly over a week, though down over longer periods. Its 14.87% total shareholder return over one year contrasts with weaker year-to-date performance, signaling cooled momentum. Current price at $32.36 sits below analyst fair value estimate of $45.54, implying undervaluation based on expected growth and profitability gains. Investments in supply chain infrastructure aim to boost margins
UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 11:59 PM EDT Orora ASX:ORA Faces Earnings Reset After Saverglass Impact and Middle East Disruptions April 10, 2026, 11:59 PM EDT. Orora (ASX:ORA) shares plunged over 8% in one day following a guidance update that revealed an earnings reset at its Saverglass unit due to Middle East supply chain disruptions and a shutdown at the Ras Al Khaimah glass plant. Despite a sharp short-term loss, Orora's 90-day share price rise exceeds 33%, contrasting a longer-term 10.58% annual total shareholder return decline amid ongoing sector pressures. Trading at A$1.49,
Go toTop